PRESS RELEASE published on 04/24/2026 at 07:00, 6 months 18 days ago BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning BB Biotech AG reports Q1 2026 results with share price outperformance, narrowing discount, and active portfolio repositioning. Eleven new investments made in biotech sector Share Price BB Biotech AG Investments Portfolio Repositioning Q1 2026
BRIEF published on 03/19/2026 at 17:45, 7 months 24 days ago L'assemblée générale annuelle de BB Biotech AG approuve les propositions et le dividende Stratégie D'investissement Assemblée Générale Annuelle Réélection Du Conseil D'administration Approbation Des Dividendes BB Biotech
BRIEF published on 03/19/2026 at 17:45, 7 months 24 days ago BB Biotech AG's AGM Approves Proposals and Dividend Annual General Meeting Investment Strategy Board Re-election Dividend Approval BB Biotech
PRESS RELEASE published on 03/19/2026 at 17:40, 7 months 24 days ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.25 per share Shareholders at BB Biotech AG's AGM approve CHF 2.25 dividend per share. Board proposals endorsed. Re-election of board members Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/20/2026 at 07:05, 8 months 20 days ago BB Biotech AG Releases 2025 Annual Report Dividend Proposal Biotechnology Sector Net Profit Increase BB Biotech 2025 Annual Report
BRIEF published on 02/20/2026 at 07:05, 8 months 20 days ago BB Biotech AG publie son rapport annuel 2025 Proposition De Dividende Augmentation Du Bénéfice Net BB Biotech Secteur De La Biotechnologie Rapport Annuel 2025
BRIEF published on 02/20/2026 at 07:05, 8 months 20 days ago BB Biotech's 2025 Annual Report Highlights Strong Financial Gains Annual Report Portfolio Value Shareholder Returns BB Biotech Financial Gains
BRIEF published on 02/20/2026 at 07:05, 8 months 20 days ago Le rapport annuel 2025 de BB Biotech met en lumière d'importants résultats financiers. Rapport Annuel BB Biotech Valeur Du Portefeuille Rendements Pour Les Actionnaires Gains Financiers
PRESS RELEASE published on 02/20/2026 at 07:00, 8 months 20 days ago EQS-Adhoc: BB Biotech AG publishes its 2025 annual report BB Biotech AG releases its 2025 annual report, reporting a strong performance with a +34.2% total return in CHF. The annual report includes detailed information on the biotechnology sector and the company's investments Financial Results Investment BB Biotech AG Biotechnology Sector 2025 Annual Report
PRESS RELEASE published on 02/20/2026 at 07:00, 8 months 20 days ago Annual Report 2025: BB Biotech delivers strong performance and portfolio value realization BB Biotech AG's Annual Report 2025 showcases strong performance and portfolio value realization. Shareholder returns, active capital management, and refined investment processes highlighted BB Biotech AG Portfolio Value Shareholder Returns Annual Report 2025 Investment Processes
Published on 11/13/2026 at 02:40, 1 hour 50 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 2 hours 20 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 5 hours 5 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 5 hours 25 minutes ago Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 5 hours 30 minutes ago Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening
Published on 11/12/2026 at 23:10, 5 hours 19 minutes ago DeFi Technologies Inc. Announces Third Quarter 2026 Financial Results with Revenue of $18.3 Million, Operating Income of $7.0 Million, and Net Income of $22.3 Million
Published on 11/12/2026 at 22:35, 5 hours 54 minutes ago Silverfort Named a Leader in the IDC MarketScape for Worldwide Augmented Identity Security Solutions 2026 Vendor Assessment
Published on 11/12/2026 at 19:50, 8 hours 40 minutes ago Eurobattery Minerals receives shareholder requests for additional items on the agenda of the upcoming Extraordinary General Meeting
Published on 11/12/2026 at 18:25, 10 hours 4 minutes ago OMAN AWARDS TWO GREEN HYDROGEN PROJECTS IN DUQM AND LAUNCHES ROUND 4 GREEN-POWERED DATA CENTRE HYDROGEN AUCTION AT COP31
Published on 11/12/2026 at 18:14, 10 hours 16 minutes ago EQS-Adhoc: HUGO BOSS AG: Daniel Grieder to step down as CEO of HUGO BOSS effective December 31, 2026 - David Epstein appointed as CEO effective January 1, 2027
Published on 11/12/2026 at 23:12, 5 hours 17 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 5 hours 17 minutes ago Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 5 hours 30 minutes ago Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 9 hours 53 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:36, 9 hours 53 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/10/2026
